HCW BiologicsHCWB
13F holders, Q2 2026 (June 30)12holders
1famous investor
$4.98avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding HCW Biologics Inc. (HCWB) in their 13F filings. The largest holders were Jane Street Group, LLC ($260K), Citadel Advisors ($100K) and HRT Financial LP ($67K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R303
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $18K |
| Exits | 0 | $0 |
Ownership 12 holders
| Jane Street Group, LLC | 0.00% | Add +2113.3% | 52,138 | $260K |
| Citadel Advisors | 0.00% | Add +358.7% | 19,942 | $100K |
| HRT Financial LP | 0.00% | Reduce -69.4% | 13,583 | $67K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +1952.5% | 6,510 | $32K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +66.5% | 4,117 | $21K |
| Connective Capital Management, LLC | 0.01% | New | 3,338 | $17K |
| Vanguard Capital Management LLC | 0.00% | No change | 2,003 | $10K |
| Golden State Wealth Management, LLC | 0.00% | No change | 1,667 | $8K |
| Barclays PLC | 0.00% | New | 191 | $953 |
| Osaic Holdings, Inc. | 0.00% | Reduce -7.7% | 4 | $20 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 11 | $10 |
| UBS Group AG | 0.00% | Reduce -99.9% | 1 | $5 |
"% of holder's portfolio" is HCWB's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.